The trusted source for
healthcare information and
By Jill Drachenberg, Editor, Relias Media
As 2018 nears its close, the Centers for Medicare & Medicaid Services (CMS) is proposing some big changes for the coming year.
CMS Administrator Seema Verma this week described the proposal for new types of section 1332 State Relief and Empowerment Waivers aimed at giving states greater control over Medicaid plans. Verma laid out the following four waivers at the States and Nation Policy Summit of the American Legislative Exchange Council:
Also announced this week was the CMS plan to “strengthen and modernize” Medicare Part C and D programs by giving them more negotiating power to lower drug costs by contract year 2020. Plans include eliminating the pharmacy gag clause that prevented pharmacists from informing patients of a lower cash payment option outside of Part D; more flexibility to manage six “protected class” drugs (antidepressants, antipsychotics, anticonvulsants, immunosuppressants, antiretrovirals, and antineoplastics) and negotiate greater discounts; and requiring drug pricing information in the Part D Explanation of Benefits. The proposed Part D rule is available in the Federal Register, and the comment period closes Jan. 25, 2019.